Approved uses of platform data
The following research proposals include both those approved by the platform’s independent Data Access Committee and those which are ISARIC Partner Analyses. Please review these proposals before submitting a Data Access Request. In the interest of maximising the production of evidence to reduce the impact of COVID-19, the platform aims to avoid unnecessary duplication of analyses.
i
Credit: National Institute of Allergy and Infectious Diseases, NIH
DAC approved proposals
These analyses have been approved by the COVID-19 Data Access Committee.
The interactive effect of clinical and non-clinical features in COVID-19 patients with chronic respiratory diseases (CRDs): a global perspective
Tsinghua University, China, Karolinska Institute, Sweden, and University College London, UK
The impact of SARS-CoV-2 variants of concern on disease severity of children
University of Queensland, Australia, NIHR Clinical Research Facility Southampton and University of Southampton, UK
Predicting hospitalisation of COVID-19 patients using intelligent wearable technology with machine learning
Durban University of Technology, South Africa
Global COVID-19 Clinical Data Platform for clinical characterization and management of hospitalized patients with suspected or confirmed COVID-19
World Health Organization, Switzerland
Formative Evaluation of a Minimally Viable COVID-19 Dataset
C-Path, United States
Pathogen evolution towards Evolutionarily Stable Strategies (ESS) in a socially age-structured epidemic
University of Oslo, Norway, University of Copenhagen, Denmark
Avoiding preventable deaths through the provision of essential treatment in critical illness in the COVID-19 pandemic
London School of Hygiene & Tropical Medicine and Centre for Global Development, UK, Ifakara Health Institute, Tanzania, and Karolinska Institute, Sweden
Sepsis in COVID-19
Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China
COVID-Intelligence, a Bayesian Network Clinical Decision Support System for COVID-19
Monash University, Australia
Clinical presentation and outcome of hospitalised Dutch patients with COVID-19
Franciscus Gasthuis and Vlietland, Rotterdam, The Netherlands
ISARIC Partner Analyses
These analyses are submitted by researchers who contribute data to the ISARIC collaboration, and approved by the ISARIC governance committees.
ISARIC COVID-19 Clinical Data Reports
Data from the ISARIC collaboration are continuously analysed, reported and made available to the clinical, research, and public health communities.
Variation in management and outcomes of hospitalised patients with COVID-19 among low-middle-, upper-middle- and high-income countries
King Saud Bin Abdulaziz University for Health sciences, King Abdullah International Medical Research Center, and King Abdulaziz Medical City, Saudi Arabia
Exploring associations between ethnicity, in-hospital complications and COVID-19 outcomes in the United Kingdom, Brazil, and South Africa
Liverpool School of Tropical Medicine, UK, Oswaldo Cruz Foundation and Pontifical Catholic University of Rio de Janeiro, Brazil, National Institute for Communicable Diseases, South Africa
Statistical and machine learning methods for predicting risk of pulmonary embolism and death in patients with COVID-19
University of Oxford and Queen Elizabeth Hospital, UK, Digital Health Research and Innovation Unit, Malaysia
Comparing clinical presentation and outcomes of hospitalised SARS-CoV-2 patients before and after the spread of the Omicron variant
University of Oxford, UK, National Institute of Communicable Diseases, South Africa, King Abdulaziz Medical City, Saudi Arabia, Sunnybrook Health Sciences Centre, Canada, University College Dublin, Ireland, Franciscus Gasthuis & Vietland, Netherlands, University Hospital of Tubingen, Germany
The relative influence of clinical and sociodemographic variables on the long-term COVID-19-associated QALYs lost
Harvard University, USA, University of Oxford and Imperial College London, UK, Universidad de La Sabana, Colombia, Oslo University Hospital, Norway
Impact of COVID-19 in Pregnancy
Mount Kenya University and Ministry of Health, Kenya, University of Oxford and University of Birmingham, UK, Ifakara Health Institute, Tanzania
Automatic Identification of Signals in Clinical Notes using Natural Language Processing
University of Oxford
A tool-box for epidemic research: the ISARIC Clinical Characterisation group on strategies to simplify and improve collaboration-fuelled research during health emergencies
University of Oxford, UK, Apollo Hospitals, India, National Public Health Institute, Liberia
Cardiovascular comorbidities and complications in hospitalized patients with COVID-19
University of Oxford, UK, Serdang Hospital and Centre for Clinical Outcome Research, Malaysia
Characteristics, presentation, risk factors, treatments and outcomes in patients with cancer and COVID-19 (ARC: ISARC International Cancer)
University of Oxford and University of Liverpool, UK, and Universidad del Cauca and Pontificia Universidad Javeriana, Colombia
Characterising SARS-CoV-2 Omicron vs Delta variant in terms of vaccination status, clinical presentation and outcomes
University of Oxford, UK
Clinical outcomes in children with severe Covid-19: a retrospective study in limited vs. enormous resource countries
National Cardiovascular Center Harapan Kita, Universitas Udayana, and Saiful Anwar Hosptial, Indonesia, and Chonnam National University Children’s Hospital, South Korea
Liver function abnormalities in patients admitted with COVID-19 and association with outcomes: A draft analysis plan using data collected by the ISARIC Collaborators
Apollo Hospitals, India, University of Toronto, Canada, and University of Oxford, and ISARIC, UK
Applicability of commonly used COVID-19 clinical case definitions and severity score amongst patients hospitalized with COVID-19 in LMICs
Clinical Research Unit Nepal and Centre for Tropical Medicine and Global Health, University of Oxford, UK
Potassium in COVID-19 patients admitted to hospital
Inserm, Nancy Regional and University Hospital Center and INI-CRCT Network, France, and Hospital Civil de Guadalajara, Mexico
Influence of nutrition status on COVID-related outcome
CUB-Hopital Erasme, Belgium
Utility of measures of oxygenation for COVID-19 case management and outcome
University of Oxford, UK, Apollo Hospitals Group, India, and Luxembourg Institute of Health, Luxembourg
Coagulopathy and thrombosis among COVID-19 patients
University of Utah School of Medicine, USA and Fundação Oswaldo Cruz, Brazil